why choose us

First received: November 03, 2022

Clinical Trial: A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Solid Tumors

Study Type: INTERVENTIONAL


Official Title: An Open-label, Non-randomized Phase I Investigation of Human ADME (Absorption, Distribution, Metabolism and Excretion) and Absolute Oral Bioavailability of BI 907828 in Patients With Advanced Solid Tu

Brief Summary: This study is open to adults with advanced cancer (solid tumours).People for whom previous treatment was not successful or no treatment exists can take part.This study tests a medicine called BI 907828.BI 907828 is a so-called p53-MDM2 antagonist that is being developed to treat cancer.The purpose of the study is to find out how BI 907828 is processed in the body.In the first 3 weeks, participants therefore get a single dose of BI 907828 in a labelled form.The first participants take BI 907828 as a liquid.This is…

Read more